MEI Pharma enters new CMO employment agreement; $503K salary, 40% bonus

Lite Strategy, Inc.

Dr. Richard Ghalie continues as CMO under new agreement effective Jan 16, 2024; base salary $503,165.28, target bonus 40% of base.
Termination without cause or for good reason: lump sum 12 months base, COBRA for 12 months, pro-rata bonus, 12-month option vesting acceleration.
Change in control: full vesting of options if terminated without cause in 3 months before or 2 years after CIC.
Death or disability triggers additional 12-month option vesting acceleration.
Agreement aligns terms with other senior executives; replaces prior 2016 employment letter.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.